Toxicity management after chimeric antigen receptor T cell therapy: One size does not fit 'ALL'

Sattva S. Neelapu, Sudhakar Tummala, Partow Kebriaei, William Wierda, Frederick L. Locke, Yi Lin, Nitin Jain, Naval Daver, Alison M. Gulbis, Sherry Adkins, Katayoun Rezvani, Patrick Hwu, Elizabeth J. Shpall

Research output: Contribution to journalLetter

33 Scopus citations
Original languageEnglish (US)
Pages (from-to)218
Number of pages1
JournalNature Reviews Clinical Oncology
Volume15
Issue number4
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Oncology

Cite this

Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Locke, F. L., Lin, Y., Jain, N., Daver, N., Gulbis, A. M., Adkins, S., Rezvani, K., Hwu, P., & Shpall, E. J. (2018). Toxicity management after chimeric antigen receptor T cell therapy: One size does not fit 'ALL'. Nature Reviews Clinical Oncology, 15(4), 218. https://doi.org/10.1038/nrclinonc.2018.20